A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

A complete platform, from DNA to recombinant antibodies

News

Discover Diaclone's IL-1 Beta Monoclonal Antibody product range....

Date of publication : 20/11/2020

Diaclone have developed IL-1β monoclonal antibodies (the B-A15 clone, biologically active form) and immunoassays (ELISA and ELISpot kits) to help you monitor the immune responses to diverse infections, diagnose auto-inflammatory diseases, and simply get the best out of your inflammation research.

Read more on LinkedIn

Better call Diaclone!

 

  • Proud to have participated in the development of BioNTech’s COVID-19 vaccine
    Date of publication : 21/01/2021

    The entire RD-Biotech team is proud to have participated in the development of BioNTech’s COVID-19 vaccine and thank them for putting their trust in our...

    Read more
  • New at Diaclone! SARS-CoV-2 SPIKE GLYCOPROTEIN RBD VARIANTS
    Date of publication : 21/01/2021
  • New at Diaclone - SARS-CoV-2 ELISA set
    Date of publication : 24/11/2020

    Diaclone continues to innovate and provide you with new research tools.

    Build your own serological assay with our new SARS-CoV-2 ELISA set.
    Contact Diaclone for more information...

    Read more
  • Discover Diaclone's IL-1 Beta Monoclonal Antibody product range....
    Date of publication : 20/11/2020

    Diaclone have developed IL-1β monoclonal antibodies (the B-A15 clone, biologically active form) and immunoassays (ELISA and ELISpot kits) to help you monitor the immune responses to diverse...

    Read more
  • Trail, the new Grail?
    Date of publication : 20/11/2020

    Diaclone has developed its TRAIL portfolio offering cytometry reagents, biologically active antibodies as well as kits for the determination of soluble forms of TRAIL and TRAIL receptors. Diaclone...

    Read more
  • HEK293: when the virus meets the cell...
    Date of publication : 20/11/2020

    All you need to know about HEK293 cells...

    And you, are you currently working on recombinant protein expression?

    Do you need a helping hand with the viral transfection of HEK293?

    Read more...

    Read more
  • NEW AT DIACLONE!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS
    Date of publication : 15/10/2020
    Developed in our laboratories in France Read more
  • Covid-19 Toolbox of the mAbexperts group
    Date of publication : 05/08/2020
  • Anti-S1 Domain Spike Protein is now available at Diaclone
    Date of publication : 03/08/2020


    Ideal for your COVID-19 studies...

    The antibody Anti-SARS-CoV-2 Spike S1 Protein CR3022 recognizes the S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19)...

    Read more
  • IL1RAP, a therapeutic target for oncologic treatment
    Date of publication : 31/07/2020

    IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams  have been able...

    Read more
  • Do you know the real potential of AAV?
    Date of publication : 01/07/2020

    Revealing the full potential of Adeno Associated Virus thanks to molecular biology

    Adeno-associated virus (AAV) is a small and single-strand DNA virus. In 1960, this non-enveloped entity was...

    Read more
  • What you need to know about Exosomes
    Date of publication : 01/07/2020

    “Huge opportunities”. “Many hurdles”. “Enormous potential”...

    It's just an excerpt of the several terms you'll come across if you search for them on...

    Read more
  • Complete Proteome of COVID-19
    Date of publication : 15/06/2020

    Are you familiar with all the proteins of SARS-CoV-2?

    Read more on Linked In

    Are you working on any of these proteins?

    Which one would you like to see developed and validated?

    Contact...

    Read more
  • RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1, for the quantification of rabies virus by ELISA.
    Date of publication : 15/06/2020

    Signature of  license agreement with Institut Pasteur (France) and the Winstar Institute (USA). RD-Biotech becomes the supplier of the clones D1-25 and 1112-1 and now offers the antibody pair...

    Read more
  • Patients’ Immune Battle Against COVID-19
    Date of publication : 27/05/2020

    A brief review of the expected complications of CovId-19 infection.

    Read more on Linked In

    Diaclone offers a specific range of Antibodies, ELISA and ELISpot kits for COVID-19 research that can...

    Read more
  • Fast track your Covid-19 Research with Diaclone’s CYTOKINES
    Date of publication : 26/05/2020

    Diaclone manufactures essential tools for Cytokine Storm monitoring & Immunotherapy...

    Read more
  • RD-Biotech : Here to help you in your Covid-19 related research projects
    Date of publication : 28/04/2020
  • Essential tools for COVID-19 and Immunotherapy research
    Date of publication : 03/04/2020
  • depistage
    RD-BIOTECH is proud to produce the monoclonal antibodies used in the IVD RAPID TEST COVID-19 Ag Respi-Strip developed by CorisBioConcept!
    Date of publication : 03/04/2020

    RD-BIOTECH, a major French actor in the production of monoclonal antibodies and recombinant proteins, is proud to be a qualified Partner of the Belgian company  Coris BioConcept  regarding...

    Read more
  • Future
    The Future of Therapeutic Antibody Development
    Date of publication : 12/03/2020

    The mAbexperts team has developed strong expertise in molecular biology to help you generate new formats of monoclonal antibodies.

    Read more on LinkedIn



     

    mAbexperts is a group...

    Read more
  • Antibody Humanization
    Date of publication : 05/03/2020

    Many articles about antibodies refer to the term “humanization”.  

    But what does humanization mean? What technical approaches are used to carry out such a process? What are the...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more